| Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis JL Nieto-Torres, ML DeDiego, C Verdiá-Báguena, JM Jimenez-Guardeño, ... PLoS pathogens 10 (5), e1004077, 2014 | 626 | 2014 |
| Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome JL Nieto-Torres, C Verdiá-Báguena, JM Jimenez-Guardeño, ... Virology 485, 330-339, 2015 | 552 | 2015 |
| Toward nanotechnology-enabled approaches against the COVID-19 pandemic C Weiss, M Carriere, L Fusco, I Capua, JA Regla-Nava, M Pasquali, ... ACS nano 14 (6), 6383-6406, 2020 | 549 | 2020 |
| Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival ML DeDiego, JL Nieto-Torres, JA Regla-Nava, JM Jimenez-Guardeño, ... Journal of virology 88 (2), 913-924, 2014 | 438 | 2014 |
| Zika virus infects neural progenitors in the adult mouse brain and alters proliferation H Li, L Saucedo-Cuevas, JA Regla-Nava, G Chai, N Sheets, W Tang, ... Cell stem cell 19 (5), 593-598, 2016 | 310 | 2016 |
| Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein JL Nieto-Torres, ML DeDiego, E Álvarez, JM Jiménez-Guardeño, ... Virology 415 (2), 69-82, 2011 | 292 | 2011 |
| The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis JM Jimenez-Guardeño, JL Nieto-Torres, ML DeDiego, JA Regla-Nava, ... PLoS pathogens 10 (8), e1004320, 2014 | 263 | 2014 |
| Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis C Castaño-Rodriguez, JM Honrubia, J Gutiérrez-Álvarez, ML DeDiego, ... MBio 9 (3), 10.1128/mbio. 02325-17, 2018 | 254 | 2018 |
| Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis ML DeDiego, JL Nieto-Torres, JM Jiménez-Guardeño, JA Regla-Nava, ... PLoS pathogens 7 (10), e1002315, 2011 | 229 | 2011 |
| Coronavirus virulence genes with main focus on SARS-CoV envelope gene ML DeDiego, JL Nieto-Torres, JM Jimenez-Guardeño, JA Regla-Nava, ... Virus research 194, 124-137, 2014 | 196 | 2014 |
| Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates JA Regla-Nava, JL Nieto-Torres, JM Jimenez-Guardeño, ... Journal of virology 89 (7), 3870-3887, 2015 | 164 | 2015 |
| Identification of the mechanisms causing reversion to virulence in an attenuated SARS-CoV for the design of a genetically stable vaccine JM Jimenez-Guardeño, JA Regla-Nava, JL Nieto-Torres, ML DeDiego, ... PLoS pathogens 11 (10), e1005215, 2015 | 160 | 2015 |
| Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge J Wen, A Elong Ngono, JA Regla-Nava, K Kim, MJ Gorman, MS Diamond, ... Nature communications 8 (1), 1459, 2017 | 158 | 2017 |
| A mouse model of Zika virus sexual transmission and vaginal viral replication WW Tang, MP Young, A Mamidi, JA Regla-Nava, K Kim, S Shresta Cell reports 17 (12), 3091-3098, 2016 | 155 | 2016 |
| Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E … C Fett, ML DeDiego, JA Regla-Nava, L Enjuanes, S Perlman Journal of virology 87 (12), 6551-6559, 2013 | 130 | 2013 |
| Cross-reactive Dengue virus-specific CD8+ T cells protect against Zika virus during pregnancy JA Regla-Nava, A Elong Ngono, KM Viramontes, AT Huynh, YT Wang, ... Nature communications 9 (1), 3042, 2018 | 113 | 2018 |
| CD4+ T cells promote humoral immunity and viral control during Zika virus infection A Elong Ngono, MP Young, M Bunz, Z Xu, S Hattakam, E Vizcarra, ... PLoS pathogens 15 (1), e1007474, 2019 | 80 | 2019 |
| Association analysis of vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Mexican-Mestizo women A González-Mercado, JY Sánchez-López, JA Regla-Nava, ... Genet Mol Res 12 (3), 2755-63, 2013 | 48 | 2013 |
| An overview of vaccines against SARS-CoV-2 in the COVID-19 pandemic era A Pascual-Iglesias, J Canton, AM Ortega-Prieto, JM Jimenez-Guardeño, ... Pathogens 10 (8), 1030, 2021 | 46 | 2021 |
| Spiking pandemic potential: structural and immunological aspects of SARS-CoV-2 YT Wang, S Landeras-Bueno, LE Hsieh, Y Terada, K Kim, K Ley, ... Trends in Microbiology 28 (8), 605-618, 2020 | 45 | 2020 |
